MarketCapTrends
ANIK
Anika Therapeutics Inc. (ANIK)
NASDAQ · Healthcare

Anika Therapeutics Inc. Shareholder Equity 2009–2025

Anika Therapeutics Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Anika Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 143.5M, a 6.83% decrease year-over-year.
  • Anika Therapeutics Inc. shareholder equity for 2025 were 143.5M, a 6.83% decrease from 2024.
  • Anika Therapeutics Inc. shareholder equity for 2024 were 154.0M, a 27.45% decrease from 2023.
  • Anika Therapeutics Inc. shareholder equity for 2023 were 212.3M, a 25.67% decrease from 2022.
  • Anika Therapeutics Inc. shareholder equity for 2022 were 285.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Anika Therapeutics Inc. Annual Shareholder Equity (Millions of US $)
2025$143
2024$154
2023$212
2022$286
2021$287
2020$272
2019$288
2018$264
2017$263
2016$223
2015$211
2014$178
2013$136
2012$109
2011$95
Anika Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$143
2024-12-31$154
2023-12-31$212
2022-12-31$286
2021-12-31$287
2020-12-31$272
2019-12-31$288
2018-12-31$264
2017-12-31$263
2016-12-31$223
2015-12-31$211
2014-12-31$178
2013-12-31$136
2012-12-31$109
2011-12-31$95
2010-12-31$85

Anika Therapeutics Inc. Shareholder Equity — FAQ

Anika Therapeutics Inc. (ANIK) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ANIK's shareholder equity history?

The chart and table above show Anika Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.